Skip to main content
Logo Lanthio
  • Introduction
  • Programs
  • Technology
  • Partnering
  • Publications
  • News
  • About us
☰ Show/Hide Menu

News

You are here

  1. Home
  2. News
Date
Title
  1. 06/05/2012
    Lanthio Pharma receives Eurostars grant
  2. 20/12/2012
    Lanthio Pharma licenses lanthionine-stabilized Angiotensin agonistic peptide drug to Tarix Pharmaceuticals
  3. 01/12/2011
    Lanthio Pharma appoints Bart Wuurman as CEO

Pages

  • 1
  • 2
  • © 2022 Lanthio Pharma
  • Imprint
  • Privacy Policy

Address
Lanthio Pharma BV
PO Box 719, 9700 AS Groningen
Rozenburglaan 13 B, 9727 DL Groningen
The Netherlands
Phone: +31 50 30 50 240
E-Mail: info@lanthiopharma.com

  • Introduction
  • Programs
  • Technology
  • Partnering
  • Publications
  • News
  • About us